Rankings
▼
Calendar
TEVA Q1 2021 Earnings — Teva Pharmaceutical Industries Limited Revenue & Financial Results | Market Cap Arena
TEVA
Teva Pharmaceutical Industries Limited
$37B
Q1 2021 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$4.0B
-8.6% YoY
Gross Profit
$1.9B
47.2% margin
Operating Income
$434M
10.9% margin
Net Income
$77M
1.9% margin
EPS (Diluted)
$0.07
QoQ Revenue Growth
-10.6%
Cash Flow
Operating Cash Flow
-$405M
Free Cash Flow
-$555M
Stock-Based Comp.
$31M
Balance Sheet
Total Assets
$49.0B
Total Liabilities
$38.0B
Stockholders' Equity
$10.0B
Cash & Equivalents
$1.7B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$4.0B
$4.4B
-8.6%
Gross Profit
$1.9B
$2.1B
-9.0%
Operating Income
$434M
$191M
+127.2%
Net Income
$77M
$69M
+11.6%
Revenue Segments
Product
$3.5B
87%
Distribution Service
$308M
8%
Product and Service, Other
$162M
4%
License
$49M
1%
Geographic Segments
North America Segment
$2.0B
54%
Europe Segment
$1.2B
33%
International Markets
$490M
13%
← FY 2021
All Quarters
Q2 2021 →